Podcasts about fda eua

Nov 16, 2021In the Hot Notes: Alex Jones is on the hook for all legal fees stemming from Sandy Hook lawsuits; Mnuchin and Pompeo discussed ousting Trump on January 6th; Michael Flynn pressured contacts within the Department of Defense to overturn the 2020 election; Pfizer is seeking FDA EUA for it's covid 19 antiviral pill; plus Allison and Dana deliver your Good News.Our Guest:Rick Smithhttps://twitter.com/RickSmithShowhttps://www.thericksmithshow.com/Ruth Ben-Ghiat, author of STRONGMENhttps://www.bookbub.com/books/strongmen-by-ruth-ben-ghiat-2021-1 Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill substack|Muellershewrote, twitter|@MuellerSheWrote, threads|@muellershewrote, TikTok|@muellershewrote, IG|muellershewroteDana Goldbergtwitter|@DGComedy, IG|dgcomedy, facebook|dgcomedy, IG|dgcomedy, danagoldberg.comHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/Patreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

In his weekly clinical update, Dr. Griffin reviews the recent statistics on SARS-CoV-2 infection, before discussing methods for sterilizing filtering facepieces, an update to the fall COVID boosters, the emergency use application of a pre-exposure prophylactic and where to find it and drug interaction database, convalescent plasma, the effectiveness of the monoclonal antibody sotrovimab against Omicron variants, what to do when healthcare workers succumb to SARS-CoV-2 infection, the need for better nursing resources, how survivors of COVID-19-associated ARDS exhibited sustained elevation in endothelial dysfunction biomarkers, correlating with the severity of impaired gas exchange, reactivation of latent CMV as a consequence of a SARS-CoV-2 infection, identification of variables that might impact or predict a person's time to recovery from an acute SARS-CoV-2 infection and if COVID-19 patients really have olfactory dysfunction more often than normally smelling individuals. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode COVID-19 national trend (CDC) COVID-19 deaths (CDC) Comparison of methods for sterilizing filtering facepiece respirators (American Journal of Infection Control) Booster update already! KP.2 of JN.1-lineage (FDA) EUA for pemgarda (FDA) Where to get pemgarda (Pemgarda) CDC Quarantine guidelines (CDC) Early phase of SARs-CoV-2 infection (COVID.gov) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) Revisiting monoclonal antibody therapy, sotrovimab for treatment during Omicron BA.2 and BA.5 (Infection) What do when your healthcare provider is infected with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Hospital nurse staffing variation & COVID-19 (International Journal of Nursing Studies) Endothelial dysfunction and persistent inflammation severe post-COVID-19 (BMC Medicine) Prevalence and risk for CMV reaction due to COVID-19 pneumonia (PLoS One) Variables that impact recovery from acute SARS-CoV-2 infetion (JAMA Network Open) Reduced olfactory bulb volume with dysfunction after mild SARS-CoV-2 inction (Scientific Reports) Contribute to our Floating Doctors fundraiser Letters read on TWiV 1124 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Some people still think these MRNA vaccines are FDA approved so let's talk about it. (4 May 2021) --- Send in a voice message: https://podcasters.spotify.com/pod/show/sirthomas-snell/message

Is your facility ready for fall immunizations? Quality Insights Infection Preventionist Jennifer Brown reviews what nursing homes need to know about the upcoming season's immunizations and the latest guidance. Related links:View Video RecordingDownload Presentation SlidesCDC recommendation for updated COVID-19 vaccinePress release regarding FDA EUA for updated mRNA COVID-19 vaccinePfizer pageModerna pageHealth care provider letters: https://www.fda.gov/media/167210/download?attachmenthttps://www.fda.gov/media/171951/download?attachment Check out our other interviews by visiting https://www.qualityinsights.org/qin/multimedia  This material was prepared by Quality Insights, a Quality Innovation Network - Quality Improvement Organization under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this material do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. Publication number 12SOW-QI-GEN-091323-CC-A 

Pink Sheet reporters and editors discuss changes to the standard for some COVID-19 treatment emergency use authorizations, late-coming COVID-19 vaccines and their potential effect on the market, and an upcoming HHS biosimilar use and cost study.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263   Overview: The FDA's recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer's Paxlovid and Merck's molnupiravir antiviral agents and give you the information you need to confidently prescribe them.   Episode resource links: FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov) FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov) Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263   Overview: The FDA's recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer's Paxlovid and Merck's molnupiravir antiviral agents and give you the information you need to confidently prescribe them.   Episode resource links: FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov) FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov) Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

Canary Cry News Talk #438 - 01.26.2022 DEEP WAR X WEBSITE/SHOW NOTES: CanaryCryNewsTalk.com SUPPLY DROP: CanaryCrySupplyDrop.com LINKTREE: CanaryCry.Party SUPPORT: CanaryCryRadio.com/Support MEET UPS: CanaryCryMeetUps.com ravel Podcast (Basil's other podcast) Facelikethesun Resurrection (Gonz' new YouTube channel) Truther Dating App (Created by Canary Cry Producers; not affiliated)   INTRO @facelikethesun back on twitter Speakpipe Hallelujah Denmark: Ending all C19 restrictions Feb 1   FLIPPY Can robots give good hugs? (Hackaday)   COVID19/I AM WACCINE Clip: Fauci wants 4 year olds get triple jab (NY Post) → 7 dead, 666 infected in Indian town (Tribune India) Omicron matches Delta in death numbers (Yahoo/BBC) → Pfizer initiate Omicron based vax in adults 18-55 (Pfizer) → Israel mulls over 4th booster offering (Rueters) Biden withdraws mandate after Supreme Court, OSHA backs off (CNBC) → [Supreme Court Beyer to retire, dems confident to replace (CNN)] → Kamala could become SC Justice (Breitbart)] FDA halts use to antibody drug, doesn't work against Omicron (AP) Neil Young threatens to take off music from Spotify over JRE “disinformation” (,Star) → CRISPR: Mammoth biosciences receives FDA EUA for C19 test (Business Wire)   Party Pitch///BREAK 1: Executive Producers, Paypal, Patrons POLYTICKS Clip: Russia threat rising (World News) → CNN: The end of the World Order (CNN) →Wisconsin to reclaim electors (Gateway Pundit, Clip) Why pay TV ops are dropping Trump-loving cable networks (LA Times) Great Reset: Anti-Great Reset GOP event, America21 (Digital Journal)   BREAK 2: Art, Reviews, Jingles, Meet Ups   GATES OF THE GODS → CERN observes X Particles for the first time (Live Science) ELON/CYBORG/SPACE Elon Musk Nerualink chip is outdated, claims BCI expert (Observer) [Daily Beast Article] → Ultra thin brain sensor reads brain with record breaking accuracy (Interesting Engineering) → Scientists discover brain mechanism capable of improving neurocomputer (TASS) →→ Space: Out of control SpaceX rocket might crash into moon (BBC) →→ Space: Russia, China to sign Lunar station deal soon (TASS)   ADDITIONAL STORIES: Footage of penguins in Antarctica jumping off of a melting piece of ice (InEntertainment) Woman tried to buy a child at Walmart (MYSA) Facebook can sell your prayers [old story, recycle?] (Input Mag) Elephant Island, north of Antarctica, why you can visit but not stay (The Travel) → High speed internet coming to Antarctica (The Verge, Nov 2021) China gives Fight Club new ending (Telegraph) IMF urges El Salvador to remove Bitcoin as legal tender (BBC, Yahoo) China builds giant military robot (Futurism) Moderna partner Metagenomi adds $175 million, Bayor, new biotech (Fierce Biotech) Babbitt punched protestors in the face before getting shot, footage (Epoch Times)   PRODUCERS for EPISODE 438 Executive Producer Sir Aaron Knight of the Cute Little Piggies**   Canary Cry Supply-Drop Sir Sammons Knight of the Fishes Kori H Dawn M   Producers Belkis, Benjamin H, MORV, Christian D, Sir Scott Knight of Truth, HeatherSirRuss, JC, Isaac G, Palmer B, Runksmash, Sir Casey the Shield Knight, Mark S, Child of God, Jackie U, Veronica D, Gail M, DrWhoDunDat, Amanda P TIMESTAMPS: Jackie U   AUDIO PRODUCTION (Jingles, Iso, Music): Leirbag3000   ART PRODUCTION (Drawing, Painting, Graphics): Dame Allie of the Skillet Nation Sir Dove Knight of Rustbeltia Palmer B   CONTENT PRODUCTION (Microfiction etc.) Runksmash - Whilst examining the data on an old drive A61GAI7 is unimpressed, there is only chatter about some ancient combat, and some form of antiquated art. As she began loosing hope she hears an ape emulate the mew of the supreme ones! They were intelligent!

In COVID-19 clinical update #94, Daniel Griffin reviews the FDA EUA for Paxlovid, test to stay in school, immunity after infection, variants and therapeutics, quarantine and isolation guidelines, Molnupiravir in non-hospitalized patients, and convalescent serum in outpatients. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode FDA EUA for Paxlovid (pdf) Children and COVID-19 (pdf) Evaluation of test to stay in school, IL (MMWR) Evaluation of test to stay in school, LA (MMWR) Update on mRNA vaccine in under 5 yo (Pfizer) CDC endorses preference for mRNA vaccines (CDC) Natural immunity and protection against delta (Clin Inf Dis) Cross-neutralization post-vaccination infection (JAMA) Variants and therapeutics (NIH) Quarantine and isolation (CDC) Molnupiravir in non-hospitalized patients (NEJM) Convalescent serum for outpatients (medRxiv) Letters read on TWiV 845 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkee Send your questions for Dr. Griffin to daniel@microbe.tv

In COVID-19 clinical update #94, Daniel Griffin reviews the FDA EUA for Paxlovid, test to stay in school, immunity after infection, variants and therapeutics, quarantine and isolation guidelines, Molnupiravir in non-hospitalized patients, and convalescent serum in outpatients. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode FDA EUA for Paxlovid (pdf) Children and COVID-19 (pdf) Evaluation of test to stay in school, IL (MMWR) Evaluation of test to stay in school, LA (MMWR) Update on mRNA vaccine in under 5 yo (Pfizer) CDC endorses preference for mRNA vaccines (CDC) Natural immunity and protection against delta (Clin Inf Dis) Cross-neutralization post-vaccination infection (JAMA) Variants and therapeutics (NIH) Quarantine and isolation (CDC) Molnupiravir in non-hospitalized patients (NEJM) Convalescent serum for outpatients (medRxiv) Letters read on TWiV 845 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkee Send your questions for Dr. Griffin to daniel@microbe.tv

Oral antiviral medications against COVID include Mulnupiravir (already with FDA EUA) and Paxlovid. They decrease risk of death and hospitalization from COVID, but not as well as vaccination. --- Send in a voice message: https://anchor.fm/covidupdates/message

In COVID-19 clinical update #92, Dr. Griffin reviews emerging data on the Omicron variant, much information about monoclonal antibody treatment, including expansion of EUA for Lilly's cocktail, FDA EUA for pre-exposure prophylaxis, outcomes after treatment, and investigation of subcutaneous or intramuscular administration; effect of adding immunomodulatory agents to usual care on thromboembolic events, and long COVID following infection in previously vaccinated individuals. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Risk associated with Omicron (medRxiv) Expansion of monoclonal EUA (FDA) Neutralization of Omicron by sera (medRxiv) Third dose sera neutralize Omicron (Pfizer) Monoclonals authorized for PreP (FDA) Patient outcomes after monoclonals (Open Forum Inf Dis) Subcutaneous or intramuscular monoclonals (medRxiv) WHO does not recommend convalescent serum (WHO) Immunomodulation and thromboembolic risk (J Clin Med) Long COVID after infection of vaccinated (medRxiv) Letters read on TWiV 840 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In COVID-19 clinical update #92, Dr. Griffin reviews emerging data on the Omicron variant, much information about monoclonal antibody treatment, including expansion of EUA for Lilly's cocktail, FDA EUA for pre-exposure prophylaxis, outcomes after treatment, and investigation of subcutaneous or intramuscular administration; effect of adding immunomodulatory agents to usual care on thromboembolic events, and long COVID following infection in previously vaccinated individuals. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Risk associated with Omicron (medRxiv) Expansion of monoclonal EUA (FDA) Neutralization of Omicron by sera (medRxiv) Third dose sera neutralize Omicron (Pfizer) Monoclonals authorized for PreP (FDA) Patient outcomes after monoclonals (Open Forum Inf Dis) Subcutaneous or intramuscular monoclonals (medRxiv) WHO does not recommend convalescent serum (WHO) Immunomodulation and thromboembolic risk (J Clin Med) Long COVID after infection of vaccinated (medRxiv) Letters read on TWiV 840 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Today, in the Hot Notes: Alex Jones is on the hook for all legal fees stemming from Sandy Hook lawsuits; Mnuchin and Pompeo discussed ousting Trump on January 6th; Michael Flynn pressured contacts within the Department of Defense to overturn the 2020 election; Pfizer is seeking FDA EUA for it's covid 19 antiviral pill; plus Allison and Dana deliver your Good News. Our Guests: Rick Smith https://twitter.com/RickSmithShow https://www.thericksmithshow.com/ Follow AG and Dana on Twitter: Dr. Allison Gill  https://twitter.com/allisongill https://twitter.com/MuellerSheWrote https://twitter.com/dailybeanspod Dana Goldberg https://twitter.com/DGComedy Follow Aimee on Instagram: Aimee Carrero (@aimeecarrero) Ruth Ben-Ghiat, author of STRONGMEN https://www.bookbub.com/books/strongmen-by-ruth-ben-ghiat-2021-11-11 Have some good news, a confession, a correction, or a case for Beans Court? https://www.dailybeanspod.com/confessional/ Want to support the show and get it ad-free and early? https://dailybeans.supercast.tech/ Or https://patreon.com/thedailybeans Promo Codes Helix is offering up to $200 off ALL mattress orders for our listeners. Use this link http://helixsleep.com/DAILYBEANS. Find out how Upstart can lower your monthly payments today when you go to http://UPSTART.com/DAILYBEANS. No matter what size or shape you are, Tom Boy X has the underwear that all bodies will love. Go to http://TomBoyX.com and enter code DAILYBEANS to get an extra 20% off. That's an extra 20% off when you enter DAILYBEANS. Cometeer is truly one of the best, if not the best tasting cups of coffee I've ever had; If you like coffee at all, this is a taste to believe product: That's cometeer.com/BEANS20 to save $20 on your first order. Get 20% off your first purchase of ANY Munk Pack product by visiting http://MunkPack.com and entering our code DAILYBEANS at checkout. Munk Pack: Delicious, nutritious food you can count on. Learn more about your ad choices. Visit megaphone.fm/adchoices

Reports of Newsome being vaccine injured are all over the place. Children's Health Defense reported it first. Robert F. Kennedy Jr made a great point! If this is true, how dare he push mandates on Californians and the children! FBI raided PV for Ashley BIden's journal. Sus .. there is nothing to hide and everything in it isn't true. Wonder what they don't want out? Pfizer BioNTech is pushing for the booster to undergo FDA EUA for everyone over 18. Biden administration pushing to continue the mandates against the 5th circuit wishes. And prepare for the worst with the possible shut down of Pipeline #5. It's going to be a dark winter.

輝瑞宣布其研發的抗新冠口服藥可以降低89%的住院或死亡風險 默克的 Molnupiravir 莫納皮拉韋出現強勁對手！ 輝瑞，又是輝瑞......疫苗也是你，藥物也是你@@ 1.先提醒，這是新聞稿，詳細的資料還沒有公布。 2.藥物商品名：PAXLOVID™ (PF-07321332; ritonavir) 是蛋白酶抑制劑的組合。PF-07321332是新藥，加上老藥抗愛滋藥物低劑量ritonavir的目的不是抗病毒效果，而是減緩新藥代謝的速度，從而增加新藥濃度。這是在抗愛滋藥物中已經經過長期使用的做法。 3.Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) 是隨機，雙盲的臨床試驗，從7月開始收案，原本預計收案3000人。收案條件是在發病五天內，輕症到中症的新冠確診病患。且因為主要想看藥物是否可以減少住院和重症，收案者需要至少有一個易重症高風險因子。此收案條件和莫納皮拉韋一模一樣。 4.目前是期中分析在9月29日前收案的1219人。若在有症狀3天內就服用藥物，用藥組389人中僅3人需要住院，0人死亡。對照組385人中27人需要住院，其中7人死亡。達到統計學上顯著意義。 (p

The final CDC approval for boosters includes people with occupational exposure despite its removal from the FDA EUA by the CDC's ACIP. It also retains recommendations for proponents with certain health risks both age 50 to 64 and age 18 to 49. --- Send in a voice message: https://anchor.fm/covidupdates/message

諾瓦瓦克斯次單位蛋白疫苗美國墨西哥臨床試驗保護力達90.4% 中重症保護力100% https://linshibi.com/?p=38720 之前美國生技公司諾瓦瓦克斯（Novavax）早在一月就公布了其研發的次單位蛋白疫苗「NVX-CoV2373」在英國執行臨床試驗有89%的保護力。現在他們發表了在美國、墨西哥進行的PREVENT-19第三期臨床試驗，收案近3萬人，保護力高達90.4%，對變種病毒株也有效，且對中重症有100%的保護力。 1.PREVENT-19第三期臨床試驗是在美國、墨西哥119個醫學中心共2萬9960人參與，2：1收案。保護力是看注射第二劑疫苗7天後發生有症狀的新冠感染，觀察期間產生了77例確診，63例在對照組，14例在疫苗組。由此估算出保護力是90.4% (95% CI: 82.9 – 94.6)。 2.確診者的嚴重程度方面，有10例中症還有4例重症，全部都發生在對照組。 疫苗組中即使得病也都是輕症，對中重症的保護力是100%。 3.其中54例有做病毒定序，全部都是變種病毒，35株（65%）是高關注變異株（Variants of Concern, VOC），9例（17%）是需留意變異株（Variants of Interest, VOI），10例（19%）是其他突變株。前兩者44例有38例發生在對照組，6例發生在疫苗組。由此估計，對變種病毒的保護力是93.2% (95% CI: 83.9– 97.1)。雖然沒有寫明，但當時在美國和墨西哥正在流行的主要變異株應該是英國變種病毒Alpha。 4.針對高風險的受試者，包括大於65歲的年長者，有慢性病或是有風險的職業等，這群人的保護力是91%。 5.安全性方面，該疫苗整體耐受性良好。產生嚴重不良事件的比例很低，且在兩組間數字相當，沒有任何一種不良反應的比例發生率超過1%。在第 1 劑和第 2 劑後7天評估時，注射部位疼痛和壓痛為最常見的局部副作用，嚴重程度通常為輕度至中度，會在3 天內恢復正常。疲勞、頭痛和肌肉疼痛是最常見的全身副作用，會在 2 天內恢復正常。 6.Novavax 計劃在今年第三季度向 FDA 申請緊急使用授權（EUA），之後預計在第3季結束前每月生產1億劑疫苗，在2021年底前提升至每月1億5000萬劑。 04b解讀： 1.要提醒這僅是新聞稿，詳細資料還沒正式發表。 2.這家Novavax公司很有趣，他1987年就創立，但一路上並不順利，多年來致力於蛋白質次單位疫苗的研發，但從來沒有任何一個疫苗成功上市。在2013年他們和瑞典的公司取得Matrix-M的佐劑專利權，之後幾個疫苗開始獲致一些成功。 3.許多朋友因為Novavax的成功，而對於同為次單位蛋白疫苗的台灣高端和聯亞也因此深具信心。我當然也希望國產疫苗可以成功，但我想不能這樣直接連結，因為就算是同樣平台，使用的蛋白結構還有佐劑都不同，次單位蛋白的成功與否可能佐劑更是重中之重，不同的疫苗效果出來可能天差地遠。 4.Novavax新冠疫苗和mRNA疫苗不同，不用儲放於超低溫環境，可在攝氏2度至8度間儲存，可使用現行疫苗供應鏈管道來配送，如同腺病毒載體疫苗一樣，應該更容易在衛生基礎建設不完善的國家運輸和普及施打。 5.目前美國FDA給予EUA的新冠疫苗是輝瑞/BNT、莫德納、嬌生疫苗，Novavax有望成為第4個被核准EUA的新冠疫苗，也可能是最後一個。另外，由於美國政府已經從這前三家藥廠那裡採購了足夠的疫苗為其國民接種，因此FDA可能會敦促 Novavax申請完全核准。 6.日本武田藥品工業從今年2月起以200位20歲以上為對象進行日本境內臨床實驗，預估這款諾瓦瓦克斯疫苗可在今年下半年推出，預定今年內向日本厚勞省申請核准。武田藥品表示日本境內一年可量產2.5億劑諾瓦瓦克斯疫苗，可穩定供貨。 Powered by Firstory Hosting

In COVID-19 clinical update #64, Daniel Griffin covers new guidance from NY on day camps, mitigation and infection rates in schools, testing to sustain in person instruction, Moderna mRNA vaccine highly effective in adolescents, longer storage of Pfizer vaccine, FDA EUA for sotrovimab, and persistent illness in UK children. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Guidance on child camps and day care (NY State) Mitigation and schools (medRxiv) Masks in elementary schools (MMWR) Testing to sustain in person instruction (MMWR) TeenCOVE results (Moderna) Pfizer/BioNTech vaccine handling and storage (CDC) EUA for sotrovimab (FDA) Illness duration in UK schoolchildren (medRxiv) Letters read on TWiV 761 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In COVID-19 clinical update #64, Daniel Griffin covers new guidance from NY on day camps, mitigation and infection rates in schools, testing to sustain in person instruction, Moderna mRNA vaccine highly effective in adolescents, longer storage of Pfizer vaccine, FDA EUA for sotrovimab, and persistent illness in UK children. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Guidance on child camps and day care (NY State) Mitigation and schools (medRxiv) Masks in elementary schools (MMWR) Testing to sustain in person instruction (MMWR) TeenCOVE results (Moderna) Pfizer/BioNTech vaccine handling and storage (CDC) EUA for sotrovimab (FDA) Illness duration in UK schoolchildren (medRxiv) Letters read on TWiV 761 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

Frank is the original co-founder of Cytosorbents, Inc., a $400 million publicly traded medical device company dedicated to saving lives through blood purification. The device is distributed globally in 67 countries with more than 120,000 total treatments, and received FDA EUA approval in April 2020 to treat adult, critically ill COVID-19 patients. It is now a recommended therapy for COVID in nineteen countries and growing. Frank raised more than $50 million for the company and established critical relationships with Fortune 500 business partners and medical thought leaders globally. He is also a co-founder, partner and investor in Game On Golf Center, a high tech golf driving range business and real estate development company with 32 acres in Westchester County, NY. Frank is also an Executive Coach and Business Consultant who helps business owners, startups, professionals, doctors, dentists and other health care professionals identify, implement and improve upon best practices to increase the profitability of their businesses while improving communications and team culture. Connect with Frank Clark here: @frankclark on Clubhouse https://www.linkedin.com/in/frankclark/​ Want to be featured on this stage? OR want a deeper conversation on Marketing Strategy? Contact Terri here: @SpinFrogs on Clubhouse @SpinFrogs on IG, FB and YouTube Terri@spinfrogs.com --- Support this podcast: https://anchor.fm/terrifictips/support

Enduring CME will expire on 10/23/2022. The presentation is originating from Northeast Georgia Medical Center Gainesville. Objectives: 1. Define convalescent plasma. 2. Review Mayo Clinic clinical trial and FDA EUA for COVID-19 convalescent plasma. 3. Discuss our Blood Bank experience with COVID-19 convalescent plasma. Disclosures: - There is no commercial support for this activity - The speakers have disclosed that there are no relevant personal or financial relationships Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.